281 related articles for article (PubMed ID: 136345)
1. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma.
Collen D
Eur J Biochem; 1976 Oct; 69(1):209-16. PubMed ID: 136345
[TBL] [Abstract][Full Text] [Related]
2. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
Müllertz S
Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.
Moroi M; Aoki N
J Biol Chem; 1976 Oct; 251(19):5956-65. PubMed ID: 134998
[TBL] [Abstract][Full Text] [Related]
4. Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.
Harpel PC
J Clin Invest; 1981 Jul; 68(1):46-55. PubMed ID: 6166634
[TBL] [Abstract][Full Text] [Related]
5. The primary inhibitor of plasmin in human plasma.
Müllertz S; Clemmensen I
Biochem J; 1976 Dec; 159(3):545-53. PubMed ID: 137718
[TBL] [Abstract][Full Text] [Related]
6. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
Aoki N; Moroi M; Matsuda M; Tachiya K
J Clin Invest; 1977 Aug; 60(2):361-9. PubMed ID: 68962
[TBL] [Abstract][Full Text] [Related]
7. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
Müllertz S; Thorsen S; Sottrup-Jensen L
Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
[TBL] [Abstract][Full Text] [Related]
8. The interaction in human plasma of antiplasmin, the fast-reacting plasmin inhibitor, with plasmin, thrombin, trypsin and chymotrypsin.
Edy J; Collen D
Biochim Biophys Acta; 1977 Oct; 484(2):423-32. PubMed ID: 143966
[TBL] [Abstract][Full Text] [Related]
9. Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.
Gonias SL; Einarsson M; Pizzo SV
J Clin Invest; 1982 Aug; 70(2):412-23. PubMed ID: 6178757
[TBL] [Abstract][Full Text] [Related]
10. Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes.
Harpel PC; Mosesson MW
J Clin Invest; 1973 Sep; 52(9):2175-84. PubMed ID: 4269529
[TBL] [Abstract][Full Text] [Related]
11. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
Thorsen S; Müllertz S; Suenson E; Kok P
Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
[TBL] [Abstract][Full Text] [Related]
12. The contribution of plasma protease inhibitors to antiplasmin activity in man.
Crawford GP; Ogston D; Douglas AS
Clin Sci Mol Med; 1976 Aug; 51(2):215-8. PubMed ID: 60190
[TBL] [Abstract][Full Text] [Related]
13. Regulation of streptokinase-human plasmin complex by the plasma proteinase inhibitors alpha 2-antiplasmin and alpha 2-macroglobulin is species specific and temperature dependent.
Gonias SL; Figler NL; Braud LL
Blood; 1988 Nov; 72(5):1658-64. PubMed ID: 2460159
[TBL] [Abstract][Full Text] [Related]
14. Production of the modified form of human plasminogen by alpha 2-macroglobulin-plasmin complexes.
Yamamoto J; Okamoto U; Morita S; Asada N; Yamaoka M
Jpn J Physiol; 1985; 35(6):1013-21. PubMed ID: 2422420
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of urokinase by complex formation with human alpha1-antitrypsin.
Clemmensen I; Christensen F
Biochim Biophys Acta; 1976 Apr; 429(2):591-9. PubMed ID: 1083251
[TBL] [Abstract][Full Text] [Related]
16. [The effect of plasmin and its complexes with alpha 2-antiplasmin and alpha 2-macroglobulin on secretion of proteinase and plasminogen inhibitors from peripheral mononuclear cells].
Zhabin SG; Zorin NA; Musatov MI
Vopr Med Khim; 1995; 41(3):34-7. PubMed ID: 8585176
[TBL] [Abstract][Full Text] [Related]
17. Prevention of plasmin autodigestion by human plasma alpha2-macroglobulin.
Toki N; Ishihara H; Yamura T
Scand J Haematol; 1977 Sep; 19(3):281-6. PubMed ID: 71756
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes.
Wohl RC; Arzadon L; Summaria L; Robbins KC
J Biol Chem; 1977 Feb; 252(4):1141-7. PubMed ID: 851483
[TBL] [Abstract][Full Text] [Related]
19. Alterations of plasmin activity, plasminogen levels and activity of antiplasmins during endotoxin shock in dogs.
Aasen AO; Gallimore MJ; Ohlsson K; Amundsen E
Haemostasis; 1978; 7(2-3):164-9. PubMed ID: 77807
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin.
Clemmensen I; Petersen LC; Kluft C
Eur J Biochem; 1986 Apr; 156(2):327-33. PubMed ID: 3009181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]